Fresenius Medical Care Renal Therapies Group Llc
1 products tracked · names used in filings: Fresenius Medical Care Renal Therapies Group Llc
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Mon 09 Nov 2026🇺🇸 FDA approval
FDA approves Multibic (multibic): new active ingredient
Fresenius Medical Care Renal Therapies Group Llc; NDA219457; New active ingredient; solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Multibic multibic | Approved | 2026-11-09 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.